These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11323020)

  • 21. Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus.
    Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T
    Thromb Res; 2005; 115(4):277-85. PubMed ID: 15668187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels.
    Albornoz L; Alvarez D; Otaso JC; Gadano A; Salviú J; Gerona S; Sorroche P; Villamil A; Mastai R
    J Hepatol; 1999 Mar; 30(3):451-5. PubMed ID: 10190728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of percutaneous lower-extremity arterial interventions on endothelial function and inflammation response in patients with both type 2 diabetes and lower-extremity peripheral arterial disease.
    Du Y; Wang F; Qi H; Ding H; Hou L; Gao Q; Tan M; Liu Y; Xing N; Sun J
    Int J Clin Exp Pathol; 2015; 8(7):8115-21. PubMed ID: 26339379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
    Chan NN; Fuller JH; Rubens M; Colhoun HM
    Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmatic nitric oxide, but not von Willebrand Factor, is an early marker of endothelial damage, in type 1 diabetes mellitus patients without microvascular complications.
    Correa RC; Alfieri AB
    J Diabetes Complications; 2003; 17(5):264-8. PubMed ID: 12954155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired flow-mediated vasodilation in vivo and reduced shear-induced platelet reactivity in vitro in response to nitric oxide in prothrombotic, stroke-prone spontaneously hypertensive rats.
    Taka T; Ohta Y; Seki J; Giddings JC; Yamamoto J
    Pathophysiol Haemost Thromb; 2002; 32(4):184-9. PubMed ID: 12759520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on endothelial dysfunction and platelet activation in elderly hypertensive patients complicated with cerebral infarction].
    Li YN; Yuan H; Zhang MX
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):143-5. PubMed ID: 12536649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
    Schäfer A; Alp NJ; Cai S; Lygate CA; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1720-6. PubMed ID: 15242858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients.
    Morise T; Takeuchi Y; Kawano M; Koni I; Takeda R
    Diabetes Care; 1995 Jan; 18(1):87-9. PubMed ID: 7698054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation.
    Varughese GI; Patel JV; Tomson J; Lip GY
    Heart; 2007 Apr; 93(4):495-9. PubMed ID: 17005711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.
    Leurs PB; Stolk RP; Hamulyak K; Van Oerle R; Grobbee DE; Wolffenbuttel BH
    Diabetes Care; 2002 Aug; 25(8):1340-5. PubMed ID: 12145232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation.
    Zhou MS; Schulman IH; Raij L
    J Hypertens; 2010 Mar; 28(3):527-35. PubMed ID: 19898250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
    Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors.
    Arikan E; Sen S
    Clin Appl Thromb Hemost; 2005 Apr; 11(2):147-59. PubMed ID: 15821821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY
    J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma?
    Goonasekera CD; Shah V; Rees DD; Dillon MJ
    Blood Press; 2000; 9(1):16-21. PubMed ID: 10854003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
    Felmeden DC; Spencer CG; Chung NA; Belgore FM; Blann AD; Beevers DG; Lip GY
    Am J Cardiol; 2003 Aug; 92(4):400-5. PubMed ID: 12914869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.